| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Symposium Report |
1 Perinatal Research Center, University of Colorado School of Medicine, Aurora, CO, USA
Glucose is the principal energy substrate for the the fetus and is essential for normal fetal metabolism and growth. Fetal glucose metabolism is directly dependent on the fetal plasma glucose concentration. Fetal glucose utilization is augmented by insulin produced by the developing fetal pancreas in increasing amounts as gestation proceeds, which enhances glucose utilization among the insulin-sensitive tissues (skeletal muscle, liver, heart, adipose tissue) that increase in mass and thus glucose need during late gestation. Glucose-stimulated insulin secretion increases over gestation. Both insulin secretion and insulin action are affected by prevailing glucose concentrations and the amount and activity of tissue glucose transporters. In cases of intrauterine growth restriction (IUGR), fetal weight-specific tissue glucose uptake rates and glucose transporters are maintained or increased, while synthesis of amino acids into protein and corresponding insulin–IGF signal transduction proteins are decreased. These observations demonstrate the mixed phenotype of the IUGR fetus that includes enhanced glucose utilization capacity, but diminished protein synthesis and growth. Thus, the fetus has considerable capacity to adapt to changes in glucose supply by relatively common and understandable mechanisms that regulate fetal metabolism and growth and could underlie certain later life metabolic disorders such as insulin resistance, obesity and diabetes mellitus.
(Received 13 January 2006;
accepted after revision 1 February 2006;
first published online 2 February 2006)
Corresponding author W. W. Hay Jr: University of Colorado Health Sciences Center, Perinatal Research Center, F441, 13243 E. 23rd Avenue, PO Box 6508, Aurora, CO 80045, USA. Email: bill.hay{at}uchsc.edu
This article has been cited by other articles:
|
|
 |
|
  Z. V. Wang, J. Mu, T. D. Schraw, L. Gautron, J. K. Elmquist, B. B. Zhang, M. Brownlee, and P. E. Scherer PANIC-ATTAC: A Mouse Model for Inducible and Reversible {beta}-Cell Ablation Diabetes, August 1, 2008; 57(8): 2137 - 2148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Zanotti-Fregonara, C. Champion, R. Trebossen, R. Maroy, J.-Y. Devaux, and E. Hindie Estimation of the {beta}+ Dose to the Embryo Resulting from 18F-FDG Administration During Early Pregnancy J. Nucl. Med., April 1, 2008; 49(4): 679 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. O Mook-Kanamori, J J Miranda Geelhoed, E. A P Steegers, J. C M Witteman, A. Hofman, H. A Moll, C. M van Duijn, A. C S Hokken-Koelega, and V. W V Jaddoe Insulin gene variable number of tandem repeats is not associated with weight from fetal life until infancy: the Generation R Study Eur. J. Endocrinol., December 1, 2007; 157(6): 741 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. Nathanielsz and V. Padmanabhan Developmental origin of health and disease J. Physiol., April 1, 2006; 572(1): 3 - 4. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
